Taxonomic group: fungi / Basidiomycota
(Phylum: Basidiomycota)
The structure was elucidated in this paperNCBI PubMed ID: 36889998Publication DOI: 10.1016/j.jbiosc.2023.02.004Journal NLM ID: 100888800Publisher: Osaka, Japan, Amsterdam, The Netherlands: Society for Bioscience and Bioengineering
Correspondence: T.S. Chang <cts

mail.nutn.edu.tw>
Institutions: Department of Cosmetic Science, Chia Nan University of Pharmacy and Science, Tainan 717, Taiwan, Biodiversity Research Center, Academia Sinica, Taipei 115, Taiwan, Department of Food Science, National Quemoy University, Kinmen 892, Taiwan, Department of Biological Sciences and Technology, National University of Tainan, Tainan 700, Taiwan
Ganoderma sp. contains high amounts of diverse triterpenoids; however, few triterpenoid saponins could be isolated from the medicinal fungus. To produce novel Ganoderma triterpenoid saponins, biotransformation-guided purification (BGP) process was applied to a commercial Ganoderma extract. The commercial Ganoderma extract was partially separated into three fractions by preparative high-performance liquid chromatography, and the separated fractions were then directly biotransformed by a Bacillus glycosyltransferase (BsUGT489). One of the biotransformed products could be further purified and identified as a novel saponin: ganoderic acid C2 (GAC2)-3-O-β-glucoside by nucleic magnetic resonance (NMR) and mass spectral analyses. Based on the structure of the saponin, the predicted precursor should be the GAC2, which was confirmed to be biotransformed into four saponins, GAC2-3-O-β-glucoside, GAC2-3,15-O-β-diglucoside and two unknown GAC2 monoglucosides, revealed by NMR and mass spectral analyses. GAC2-3-O-β-glucoside and GAC2-3,15-O-β-diglucoside possessed 17-fold and 200-fold higher aqueous solubility than that of GAC2, respectively. In addition, GAC2-3-O-β-glucoside retained the most anti-α-glucosidase activity of GAC2 and was comparable with that of the anti-diabetes drug (acarbose). The present study showed that the BGP process is an efficient strategy to survey novel and bioactive molecules from crude extracts of natural products.
glycosyltransferase, glycosylation, Ganoderma lucidum, biotransformation, triterpenoid
Structure type: monomer
Location inside paper: Fig. 4, table S1, compound 1 (GAC2-3-O-b-glucoside)
Trivial name: ganoderic acid C2 (GAC2)-3-O-β-glucoside
Compound class: triterpenoid saponin
Biological activity: extraction,biotransformation,column chromatography,RP-HPLC,MS,1H NMR,13C NMR,DEPT,NMR-2D
Comments, role: NMR temperature was not specified
Related record ID(s): 41404
NCBI Taxonomy refs (TaxIDs): 5315
Show glycosyltransferases
NMR conditions: in C5D5N
[as TSV]
13C NMR data:
Linkage Residue C1 C2 C3 C4 C5 C6 C7 C8 C9 C10 C11 C12 C13 C14 C15 C16 C17 C18 C19 C20 C21 C22 C23 C24 C25 C26 C27 C28 C29 C30
3 bDGlcp 107.4 76.1 79.1 72.1 78.7 63.3
Subst 35.6 27.7 88.7 39.8 50.3 29.1 69.7 160.7 142.1 39.0 200.0 53.0 47.8 55.1 72.7 37.4 49.2 20.1 17.8 33.5 20.1 50.3 209.4 47.5 36.0 178.7 18.0 20.7 28.6 17.4
1H NMR data:
Linkage Residue H1 H2 H3 H4 H5 H6 H7 H8 H9 H10 H11 H12 H13 H14 H15 H16 H17 H18 H19 H20 H21 H22 H23 H24 H25 H26 H27 H28 H29 H30
3 bDGlcp 4.96 4.06 4.28 4.25 4.02 4.43-4.60
Subst 1.04-3.02 1.99-2.36 3.47 - 1.33 1.92 4.94 - - - - 2.66-2.99 - - 5.24 1.96-2.17 - - - - - - - 2.61-3.11 - - 1.36 - - -
1H/13C HSQC data:
Linkage Residue C1/H1 C2/H2 C3/H3 C4/H4 C5/H5 C6/H6 C7/H7 C8/H8 C9/H9 C10/H10 C11/H11 C12/H12 C13/H13 C14/H14 C15/H15 C16/H16 C17/H17 C18/H18 C19/H19 C20/H20 C21/H21 C22/H22 C23/H23 C24/H24 C25/H25 C26/H26 C27/H27 C28/H28 C29/H29 C30/H30
3 bDGlcp 107.4/4.96 76.1/4.06 79.1/4.28 72.1/4.25 78.7/4.02 63.3/4.43-4.60
Subst 35.6/1.04-3.02 27.7/1.99-2.36 88.7/3.47 50.3/1.33 29.1/1.92 69.7/4.94 53.0/2.66-2.99 72.7/5.24 37.4/1.96-2.17 47.5/2.61-3.11 18.0/1.36
1H NMR data:
Linkage | Residue | H1 | H2 | H3 | H4 | H5 | H6 | H7 | H8 | H9 | H10 | H11 | H12 | H13 | H14 | H15 | H16 | H17 | H18 | H19 | H20 | H21 | H22 | H23 | H24 | H25 | H26 | H27 | H28 | H29 | H30 |
3 | bDGlcp | 4.96 | 4.06 | 4.28 | 4.25 | 4.02 | 4.43 4.60 | |
| Subst | 1.04 3.02 | 1.99 2.36 | 3.47 |
| 1.33 | 1.92 | 4.94 |
|
|
|
| 2.66 2.99 |
|
| 5.24 | 1.96 2.17 |
|
|
|
|
|
|
| 2.61 3.11 |
|
| 1.36 |
|
|
|
|
13C NMR data:
Linkage | Residue | C1 | C2 | C3 | C4 | C5 | C6 | C7 | C8 | C9 | C10 | C11 | C12 | C13 | C14 | C15 | C16 | C17 | C18 | C19 | C20 | C21 | C22 | C23 | C24 | C25 | C26 | C27 | C28 | C29 | C30 |
3 | bDGlcp | 107.4 | 76.1 | 79.1 | 72.1 | 78.7 | 63.3 | |
| Subst | 35.6 | 27.7 | 88.7 | 39.8 | 50.3 | 29.1 | 69.7 | 160.7 | 142.1 | 39.0 | 200.0 | 53.0 | 47.8 | 55.1 | 72.7 | 37.4 | 49.2 | 20.1 | 17.8 | 33.5 | 20.1 | 50.3 | 209.4 | 47.5 | 36.0 | 178.7 | 18.0 | 20.7 | 28.6 | 17.4 |
|
There is only one chemically distinct structure:
Taxonomic group: fungi / Basidiomycota
(Phylum: Basidiomycota)
The structure was elucidated in this paperNCBI PubMed ID: 36889998Publication DOI: 10.1016/j.jbiosc.2023.02.004Journal NLM ID: 100888800Publisher: Osaka, Japan, Amsterdam, The Netherlands: Society for Bioscience and Bioengineering
Correspondence: T.S. Chang <cts

mail.nutn.edu.tw>
Institutions: Department of Cosmetic Science, Chia Nan University of Pharmacy and Science, Tainan 717, Taiwan, Biodiversity Research Center, Academia Sinica, Taipei 115, Taiwan, Department of Food Science, National Quemoy University, Kinmen 892, Taiwan, Department of Biological Sciences and Technology, National University of Tainan, Tainan 700, Taiwan
Ganoderma sp. contains high amounts of diverse triterpenoids; however, few triterpenoid saponins could be isolated from the medicinal fungus. To produce novel Ganoderma triterpenoid saponins, biotransformation-guided purification (BGP) process was applied to a commercial Ganoderma extract. The commercial Ganoderma extract was partially separated into three fractions by preparative high-performance liquid chromatography, and the separated fractions were then directly biotransformed by a Bacillus glycosyltransferase (BsUGT489). One of the biotransformed products could be further purified and identified as a novel saponin: ganoderic acid C2 (GAC2)-3-O-β-glucoside by nucleic magnetic resonance (NMR) and mass spectral analyses. Based on the structure of the saponin, the predicted precursor should be the GAC2, which was confirmed to be biotransformed into four saponins, GAC2-3-O-β-glucoside, GAC2-3,15-O-β-diglucoside and two unknown GAC2 monoglucosides, revealed by NMR and mass spectral analyses. GAC2-3-O-β-glucoside and GAC2-3,15-O-β-diglucoside possessed 17-fold and 200-fold higher aqueous solubility than that of GAC2, respectively. In addition, GAC2-3-O-β-glucoside retained the most anti-α-glucosidase activity of GAC2 and was comparable with that of the anti-diabetes drug (acarbose). The present study showed that the BGP process is an efficient strategy to survey novel and bioactive molecules from crude extracts of natural products.
glycosyltransferase, glycosylation, Ganoderma lucidum, biotransformation, triterpenoid
Structure type: oligomer
Location inside paper: Fig. 4, table S1, compound 4 (GAC2-3,15-O-b-glucoside)
Trivial name: ganoderic acid C2 (GAC2)-3,15-O-β-glucoside
Compound class: triterpenoid saponin
Biological activity: extraction,biotransformation,column chromatography,RP-HPLC,MS,1H NMR,13C NMR,DEPT,NMR-2D
Comments, role: NMR temperature was not specified
Related record ID(s): 41034
NCBI Taxonomy refs (TaxIDs): 5315
Show glycosyltransferases
NMR conditions: in C5D5N
[as TSV]
13C NMR data:
Linkage Residue C1 C2 C3 C4 C5 C6 C7 C8 C9 C10 C11 C12 C13 C14 C15 C16 C17 C18 C19 C20 C21 C22 C23 C24 C25 C26 C27 C28 C29 C30
3 bDGlcp 105.6 76.1 79.3 72.1 78.9 63.3
15 bDGlcp 105.6 76.1 79.3 72.1 78.9 63.3
Subst 35.7 27.7 88.7 41.4 50.2 30.1 68.1 161.2 142.7 39.7 199.9 52.8 47.4 54.6 83.2 38.8 49.6 19.7 17.9 33.4 20.0 50.3 209.4 47.3 35.9 178.7 18.0 22.1 30.1 16.7
1H NMR data:
Linkage Residue H1 H2 H3 H4 H5 H6 H7 H8 H9 H10 H11 H12 H13 H14 H15 H16 H17 H18 H19 H20 H21 H22 H23 H24 H25 H26 H27 H28 H29 H30
3 bDGlcp 4.96 4.06 4.24 4.26 4.01 4.42-4.59
15 bDGlcp 4.95 4.09 4.22 4.27 3.93 4.38-4.54
Subst 1.05-3.05 1.95-2.36 3.47 - 1.12 1.97-2.30 5.26 - - - - 2.66-2.96 - - 5.36 2.04-2.59 1.88 1.47 1.15 2.24 0.94 2.22 - 2.54-3.07 3.28 - 1.35 1.57 1.30 1.08
1H/13C HSQC data:
Linkage Residue C1/H1 C2/H2 C3/H3 C4/H4 C5/H5 C6/H6 C7/H7 C8/H8 C9/H9 C10/H10 C11/H11 C12/H12 C13/H13 C14/H14 C15/H15 C16/H16 C17/H17 C18/H18 C19/H19 C20/H20 C21/H21 C22/H22 C23/H23 C24/H24 C25/H25 C26/H26 C27/H27 C28/H28 C29/H29 C30/H30
3 bDGlcp 105.6/4.96 76.1/4.06 79.3/4.24 72.1/4.26 78.9/4.01 63.3/4.42-4.59
15 bDGlcp 105.6/4.95 76.1/4.09 79.3/4.22 72.1/4.27 78.9/3.93 63.3/4.38-4.54
Subst 35.7/1.05-3.05 27.7/1.95-2.36 88.7/3.47 50.2/1.12 30.1/1.97-2.30 68.1/5.26 52.8/2.66-2.96 83.2/5.36 38.8/2.04-2.59 49.6/1.88 19.7/1.47 17.9/1.15 33.4/2.24 20.0/0.94 50.3/2.22 47.3/2.54-3.07 35.9/3.28 18.0/1.35 22.1/1.57 30.1/1.30 16.7/1.08
1H NMR data:
Linkage | Residue | H1 | H2 | H3 | H4 | H5 | H6 | H7 | H8 | H9 | H10 | H11 | H12 | H13 | H14 | H15 | H16 | H17 | H18 | H19 | H20 | H21 | H22 | H23 | H24 | H25 | H26 | H27 | H28 | H29 | H30 |
3 | bDGlcp | 4.96 | 4.06 | 4.24 | 4.26 | 4.01 | 4.42 4.59 | |
15 | bDGlcp | 4.95 | 4.09 | 4.22 | 4.27 | 3.93 | 4.38 4.54 | |
| Subst | 1.05 3.05 | 1.95 2.36 | 3.47 |
| 1.12 | 1.97 2.30 | 5.26 |
|
|
|
| 2.66 2.96 |
|
| 5.36 | 2.04 2.59 | 1.88 | 1.47 | 1.15 | 2.24 | 0.94 | 2.22 |
| 2.54 3.07 | 3.28 |
| 1.35 | 1.57 | 1.30 | 1.08 |
|
13C NMR data:
Linkage | Residue | C1 | C2 | C3 | C4 | C5 | C6 | C7 | C8 | C9 | C10 | C11 | C12 | C13 | C14 | C15 | C16 | C17 | C18 | C19 | C20 | C21 | C22 | C23 | C24 | C25 | C26 | C27 | C28 | C29 | C30 |
3 | bDGlcp | 105.6 | 76.1 | 79.3 | 72.1 | 78.9 | 63.3 | |
15 | bDGlcp | 105.6 | 76.1 | 79.3 | 72.1 | 78.9 | 63.3 | |
| Subst | 35.7 | 27.7 | 88.7 | 41.4 | 50.2 | 30.1 | 68.1 | 161.2 | 142.7 | 39.7 | 199.9 | 52.8 | 47.4 | 54.6 | 83.2 | 38.8 | 49.6 | 19.7 | 17.9 | 33.4 | 20.0 | 50.3 | 209.4 | 47.3 | 35.9 | 178.7 | 18.0 | 22.1 | 30.1 | 16.7 |
|
There is only one chemically distinct structure: